Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1

Clinical trial NCT05614531 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05614531
Sponsor: Guangzhou Jiayin Biotech Ltd
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy Type I

Start date: 2023-02-16
Primary completion: 2025-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.